Brief: Artrya Ltd Submits FDA 510(K) Application For Salix Coronary Plaque Module
16/06/2025 02:29
June 16 (Reuters) - Artrya Ltd AYA.AX: SUBMITS FDA 510(K) APPLICATION FOR SALIX CORONARY PLAQUE MODULE Further company coverage: AYA.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Artrya
See all newsAustralia's Artrya soars on bagging fourth US commercial customer
Brief: Artrya Reports FY Loss From Ordinary Activities After Tax Attributable A$25.2 Million
Brief: Artrya Appoints Richard Jarvis As CFO
Australia's Artrya at three-week peak on deal with US co
Brief: Artrya To Raise About A$75 Mln Via Placement At Issue Price Of A$2.05 Per Share